Table 3.
Bacteriological results of urine cultures | ||||
Total patients | Community-acquired AP | Nosocomial AP | Community-acquired versus nosocomial AP | |
n = 371 | n = 295 | n = 76 | p value | |
Urine culture | 347 (94%) | 271 (92%) | 76 (100%) | 0.02 |
Sterile | 122 (35%) | 96 (35%) | 29 (38%) | 0.71 |
Positive | 225 (65%) | 178 (66%) | 47 (62%) | 0.71 |
One strain | 196 (87%) | 159 (89%) | 37 (79%) | 0.09 |
≥ 2 strains | 29 (13%) | 19 (11%) | 10 (21%) | 0.09 |
Isolated strains | 270 | 213 (79%) | 57 (21%) | < 0.001 |
E. coli | ||||
All types | 157 (58%) | 142 (68%) | 15 (26%) | < 0.01 |
Ampicillin-S | 95 (61%) | 88 (62%) | 7 (50%) | 0.4 |
Nalidixic acid-S | 119 (76%) | 110 (78%) | 9 (57%) | 0.2 |
Ofloxacin-S | 130 (83%) | 120 (85%) | 10 (64%) | 0.2 |
Cotrimoxazole-S | 122 (78%) | 115 (81%) | 7 (43%) | < 0.01 |
Proteus | 16 (6%) | 11 (5%) | 5 (9%) | 0.5 |
KES group | 24 (9%) | 18 (8%) | 6 (11%) | 0.8 |
Enterococcus | 16 (6%) | 8 (4%) | 8 (14%) | 0.02 |
P. aeruginosa | 20 (7%) | 8 (4%) | 12 (21%) | < 0.01 |
S. aureus | 8 (3%) | 3 (1%) | 5 (9%) | 0.02 |
Others | 29 (11%) | 23 (11%) | 6 (11%) | 0.9 |